Daisy Ng-Mak, PhD

Articles by Daisy Ng-Mak, PhD

Hospitalization Risk in Patients with Schizophrenia Treated with Dose-Equivalent Antipsychotics

ByDaisy Ng-Mak, PhD,Andrew Messali, PharmD, PhD,Ahong Huang, MS,Li Wang, PhD,Antony Loebel, MD

July 31st 2019

Association Between Meaningful Use of Electronic Health Records and Patient Health Outcomes in Schizophrenia: A Retrospective Database Analysis

ByDaisy Ng-Mak, PhD,Charles Ruetsch, PhD

July 12th 2019

Measuring Migraine-Related Quality of Care Across 10 Health Plans

ByValerie P. Pracilio, MPH,Stephen Silberstein, MD,Joseph Couto, PharmD, MBA,Jon Bumbaugh, MA,Mary Hopkins, RN,Daisy Ng-Mak, PhD,Cary Sennett, MD, PhD,Neil I. Goldfarb, BA

August 15th 2012

Standardized measurement of migraine, an underdiagnosed and perhaps underrecognized condition, is necessary for health plans to understand utilization of costly diagnostic and treatment services.

Daisy Ng-Mak, PhD

Articles by Daisy Ng-Mak, PhD

Hospitalization Risk in Patients with Schizophrenia Treated with Dose-Equivalent Antipsychotics

Association Between Meaningful Use of Electronic Health Records and Patient Health Outcomes in Schizophrenia: A Retrospective Database Analysis

Measuring Migraine-Related Quality of Care Across 10 Health Plans

Latest Updated Articles

Trending on AJMC

5 Things to Know About the FDA's Peptide Reversal

Moderna, Merck mRNA Cancer Vaccine Succeeds in Late-Stage Trial

FDA Approves First Orexin Agonist for Narcolepsy Type 1

Ochsner Health, Paradigm Health Partnership Expands Clinical Trial Access Across the Gulf South

Vutrisiran Associated With Slower Decline in Left Atrial Function in ATTR-CM